Julie Boyster - 31 Aug 2025 Form 4 Insider Report for Lifevantage Corp (LFVN)

Signature
/s/ Alissa Neufeld, Power of Attorney for Julie Boyster
Issuer symbol
LFVN
Transactions as of
31 Aug 2025
Net transactions value
-$305,138
Form type
4
Filing time
03 Sep 2025, 21:48:20 UTC
Previous filing
28 Aug 2025
Next filing
03 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Boyster Julie Chief Marketing Officer 3300 TRIUMPH BLVD, SUITE 700, LEHI /s/ Alissa Neufeld, Power of Attorney for Julie Boyster 03 Sep 2025 0001964003

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFVN Common Stock Options Exercise $0 +18,934 +15% $0.000000 147,250 31 Aug 2025 Direct F1
transaction LFVN Common Stock Options Exercise $0 +27,966 +19% $0.000000 175,216 31 Aug 2025 Direct F2
transaction LFVN Common Stock Tax liability $305,138 -23,293 -13% $13.10 151,923 31 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LFVN Performance Restricted Stock Units Options Exercise $0 -18,934 -75% $0.000000 6,312 31 Aug 2025 Common Stock 18,934 Direct F1, F3
transaction LFVN Performance Restricted Stock Units Options Exercise $0 -27,966 -67% $0.000000 13,983 31 Aug 2025 Common Stock 27,966 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 24, 2023, the reporting person was granted Performance Restricted Stock Units ("PRSUs") which vest upon achievement of previously established time-based and financial performance criteria.
F2 On August 26, 2024, the reporting person was granted PRSUs which vest upon achievement of previously established time-based and financial performance criteria.
F3 PRSUs convert into common stock on a one-for-one basis.